Fragment-based discovery of orphan nuclear receptor Nur77/NGFI-B ligands.

Bioorg Chem

Institute of Pharmaceutical Chemistry, Goethe University Frankfurt, 60438 Frankfurt, Germany; Department of Pharmacy, Ludwig-Maximilians-Universität München, 81377 Munich, Germany. Electronic address:

Published: December 2022

The transcription factor nerve growth factor-induced clone B (NGFI-B, Nur77, NR4A1) is an orphan nuclear receptor playing a role in cell survival and apoptosis regulation. Pharmacological Nur77 modulation holds promise for cancer and (neuro-)inflammatory disease treatment. The available Nur77 ligand scaffolds based on highly lipophilic natural products cytosporone B, celastrol and isoalantolactone are inadequate for the development of potent Nur77 modulators with favorable properties as chemical tools and future drugs. By fragment library screening and subsequent modeling for fragment extension, we have obtained a set of new Nur77 ligands offering alternative chemotypes for the development of Nur77 agonists and inverse agonists. Computer-aided fragment extension in a second stage screening yielded a Nur77 agonist with significant activation efficacy and preference over the related NR4A receptors.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bioorg.2022.106164DOI Listing

Publication Analysis

Top Keywords

orphan nuclear
8
nuclear receptor
8
fragment extension
8
nur77
7
fragment-based discovery
4
discovery orphan
4
receptor nur77/ngfi-b
4
nur77/ngfi-b ligands
4
ligands transcription
4
transcription factor
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!